Business
CSL (ASX:CSL) share price lower amid reported mRNA vaccine delays
Image source: Getty Images
The CSL Limited (ASX: CSL) share price is falling amid reports Australia might not be capable of producing mRNA vaccines until 2023.
Right now, shares in CSL are swapping hands for $276.09 – 1.33% less than yesterday’s closing price.
The fall…
Continue Reading
-
Noosa News19 hours agoAustralian chocolate gains a competitive edge in global cocoa shortage
-
General23 hours agoBudget billions helps cashed-up state lead debt battle
-
General21 hours agoHawthorn’s AFLW star Tilly Lucas-Rodd undergoes gender affirming top surgery
-
Noosa News12 hours agoInvestigations underway after dead body found on Townsville road